News Article Archives - MOMA Therapeutics

Fierce Biotech’s 2021 Fierce 15

Moma Therapeutics Going after the ATPase class of enzymes CEO: Asit Parikh Based: Brighton, Massachusetts Founded: 2020 Clinical focus: Precision oncology, synthetic lethality and cancer dependency The scoop: A clutch of successful…

Dorothee Kern’s path from basketball star to founder of billion-dollar biotech(s?); Five Prime Therapeutics hands the reins to Genentech vet

I assure you that I did not plan to do this. I wanted to write a little story about proteins and cancer, nuclear magnetic imaging and a scientist turned entrepeneur…

The newest, $86M Third Rock startup chases the tiny biological machines inside of you

It took 23 years from the isolation of the gene for cystic fibrosis to the approval of the first drug to target it, and another 7 for a drug that…

Moma Therapeutics aims at molecular machines with $86M raise

Moma Therapeutics wants to crack a new type of drug target wide open. The company snagged $86 million from the likes of Third Rock Ventures to systematically go after molecular…